Althesin will control status epilepticus when other agents jail. Its major advantage over other agents is its lack of accumulation because it is readily metabolized. Three patients are reported and relevant literature is discussed.
References
1.
ClarkeR. S. J., DundeeJ. W., CarsonI. W., AroraM. V., and McCaugheyW. (1972): “Clinical studies of althesin with various premedicants”, Brit. J. Anaesth., 44, 845.
2.
ComelliL. F., PignatelliM. G., and VarassiA. (1977): “Anaesthesiology proceedings of VI World Congress of Anaesthesiology”, AmsterdamExcerpta Medica.
3.
DavisB., and PearseD. R. (1972): “An introduction to althesin”, Postgrad. M. J., 48, supplement, 2, 13.
4.
EvansJ. M., and KeoghJ. A. M. (1977): “Adverse reactions to intravenous anaesthetic agents”, Brit. Med. J., 2, 735.
5.
ForrestA. R. W., WatrasiewiczK., and MooreC. J. (1977): “Long term althesin infusion and hyperlipidaemia”, Brit. Med. J., 2, 1357.
6.
JonesB. C. (1972): “The protein binding of alphaxalone”, Postgrad. Med. J., 48, supplement 2, 47.
7.
LaxenaireM. C., WeberM., MartinelleF., HottierM. C., and PicardJ. M. (1974): “Appreciation du Reveil par des Tests Psychomoteurs et a l'EEG apres Anaesthesie a l'Alfatesine, Glaxo-France. Ed. p 75.
8.
McGowanR. (1976): “Convulsions and althesin”, Anaesthesia, 31, 112.
9.
ReesL. T. (1975): “Convulsions immediately following althesin”, Anaesthesia, 30, 54.
10.
SamuelI. O., and DundeeJ. W. (1973): “Influence of injection rate and dosage on the induction complications with althesin”, Brit. J. Anaesth., 45, 1215.
11.
ScottD. F., and VirdenSusan (1972): “Comparison of the effects of althesin with other induction agents on electroencephalographic patterns”, Postgrad. Med. J., 48, supplement 2, 93.
12.
SwerdlowM., ChakrebortyS. K., ZahangirM. (1971): “A trial of CT1341”, Brit. J. Anaesth., 43, 1075.
13.
UppingtonJ. (1973): “Epileptiform convulsions with althesin”, Anaesthesia, 28, 546.
14.
WestreichG., and KnellerA. W. (1972): “Intravenous lignocaine for status epilepticus”, Minnesota Medicine, 55, 807.
